n August 2022, an updated version of the EU GMP Annex 1 regulatory guideline for sterile pharmaceutical products was issued, superseding the previous draft from 2020 and the existing 2008 version.
Image Credit: Panya_photo/Shutterstock.com
The deadline for implementing these new directives was August 25, 2023, exactly one year post-publication. These directives govern the production of sterile medicines manufactured within or imported into the European Union.
Pharmaceutical production occurs in regulated settings to minimize contamination, and the recent modifications introduced by Annex 1 emphasize strategic oversight rather than solely quality measurement.
This latest revision more closely aligns the manufacturing principles outlined in Annex 1 with those established by the World Health Organization (WHO), the Pharmaceutical Inspection Cooperation Scheme (PIC/S), and the US Food and Drug Administration (FDA).
This new edition represents a comprehensive overhaul of the 2008 Annex 1 and is nearly four times its original length.
It categorizes the document into 10 newly established sections. A significant structural alteration involves the distinct separation and clarification of Certification (Section 4) and Monitoring (Section 9), enabling more detailed guidance and differentiation between facility design/validation and continuous routine oversight.
A new section has also been introduced that addresses the principle of a Contamination Control Strategy (CCS). This section inaugurates a novel approach by integrating CCS as a core, encompassing methodology for understanding how each facet of contamination interacts with the entire facility.
Furthermore, there is a new section that designates Quality Risk Management (QRM) as a fundamental tenet for defining processes, operations, and acceptable thresholds, and it is linked to CCS to achieve a balance between process and risk.
As stipulated in the updated revision, the regulations pertaining to Environmental Monitoring remain largely consistent, with a few augmented descriptions to better align with QRM.
About Particle Measuring Systems
Particle Measuring Systems has 35 years of experience designing, manufacturing, and servicing microcontamination monitoring instrumentation and software used for detecting particles in air, liquid, and gas streams, as well as molecular contamination monitoring.
Specific applications include cleanroom monitoring, parenteral sampling, filter and in-line testing in deionized water and process chemicals, and point-of-use monitoring of inert gases and in-situ particle monitoring. Specialty monitoring includes parts cleanliness testing with a highly automated solution.
Particle measuring systems
Whether you want to protect a product or meet industry requirements, such as ISO 14644, USP 797, or GMP, Particle Measuring Systems has a large variety of particle counters and molecular monitors to meet your needs. With 35 years of experience, it has proven reliability to support your application.
Particle counters
Protect your product with our reliable particle counters. PMS has airborne, portable, and liquid particle counters for a wide variety of applications, including DI water, chemicals, and cleanroom monitoring. Compare particle counters or learn how to monitor your cleanroom or product by reading our papers.
Molecular contamination monitors
Molecular contamination causes costly problems for high-value products, production processes, and equipment surfaces. PMS has solutions for both Airborne Molecular contamination (AMC) and Surface Molecular contamination (SMC). With parts-per-trillion limits of detection, real-time sampling, NIST traceable calibrations, and various data analysis packages, you can monitor in confidence.
Gas detectors
If you need gas detectors for process control or continuous emissions monitoring, Particle Monitoring Systems can help. Get real-time, reliable results with its ammonia, hydrogen fluoride, and chlorine detectors for worker protection, CEMs, and pollution monitoring.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices, and treatments.